XG-102 is noninferior to dexamethasone for the treatment of postoperative ocular inflammation Jan. 18, 2017 No Comments
ThromboGenics initiates phase II trial of THR-317 for diabetic macular edema Jan. 10, 2017 No Comments
Acucela's emixustat hydrochloride granted orphan drug status in U.S. for Stargardt disease Jan. 9, 2017 No Comments
Ocular Therapeutix reports positive secondary endpoint results from Dextenza phase II study Jan. 5, 2017 No Comments
RSS